Anjan Sinha, MD
Interventional Cardiology · Indianapolis, INNPI 1033209515
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (36.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Boston Scientific at 43.5% of the total. Reporting peaked in 2019 at $26,363 and has fallen 83.0% since, to $4,473 in 2025. Among interventional cardiology clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 250 payments — averaging $215.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$23K
- Edwards Lifesciences$16K
- Cardiovascular Systems Inc.$8K
- Abbott$3K
- Abiomed$1K
- Medtronic$523
- plus $1K from 21 others
Across 9 payments — averaging $3116.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$20K
- Edwards Lifesciences$8K
What the payments were for
- Consulting fees$16,70031%
- Speaking & faculty fees$19,57536%
- Travel & lodging$9,67518%
- Food & beverage$7,86915%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 77 | $23,408 |
| Edwards Lifesciences | 39 | $16,396 |
| Cardiovascular Systems Inc. | 15 | $7,685 |
| Abbott | 38 | $3,350 |
| Abiomed | 12 | $1,017 |
| Medtronic(2 entities) | 13 | $523 |
| Shockwave Medical, Inc | 2 | $201 |
| AstraZeneca | 7 | $177 |
| Novo Nordisk | 6 | $133 |
| Biotronik Inc. | 1 | $123 |
| Cardiva Medical, Inc. | 5 | $101 |
| Pfizer | 6 | $95 |
| Terumo Medical Corporation | 3 | $88 |
| Cordis US CORP. | 4 | $81 |
| Amgen | 4 | $78 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $78 |
| Johnson & Johnson | 3 | $65 |
| E.r. Squibb & Sons, L.L.C. | 2 | $44 |
| Siemens Medical Solutions USA, Inc. | 1 | $27 |
| Teleflex LLC | 1 | $23 |
| Boehringer Ingelheim | 1 | $23 |
| Biosense Webster, Inc. | 1 | $21 |
| Philips North America LLC | 1 | $19 |
| ZOLL Circulation Inc | 1 | $18 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
| Kestra Medical Technology Services, Inc. | 1 | $15 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$12,771
- Edwards SAPIEN 3 Transcatheter Heart Valve$11,469
- Coronary Orbital Atherectomy System$7,426
- GENERAL VASCULAR ACCESS$4,800
- Watchman$4,384
- MitraClip$2,250
- PASCAL$2,169
- SAPIEN 3 Ultra RESILIA$992
- Impella$767
- COREVALVE EVOLUT R$222
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$188
- CARDIOMEMS$175
- AMPLATZER AMULET$149
- FFRangio$138
- Orsiro Mission$123
- Peripheral Orbital Atherectomy System$111
- Mitra Clip system$109
How this compares
$53,818 in reported general payments places this provider in the 90th percentile of 170 interventional cardiology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 215 | $264,130 |
| EliquisApixaban | 189 | $225,137 |
| Repatha SureclickEvolocumab | 23 | $35,949 |
| BrilintaTicagrelor | 24 | $19,664 |
| XareltoRivaroxaban | 11 | $15,187 |
| JardianceEmpagliflozin | 14 | $13,546 |
| FarxigaDapagliflozin Propanediol | 18 | $8,977 |
| Repatha SyringeEvolocumab | 13 | $6,456 |
| Prasugrel Hcl | 29 | $5,309 |
| Digoxin | 30 | $5,110 |
| Metoprolol Succinate | 251 | $4,356 |
| Rosuvastatin Calcium | 161 | $3,660 |
| ClopidogrelClopidogrel Bisulfate | 219 | $2,600 |
| Torsemide | 144 | $2,533 |
| Atorvastatin Calcium | 242 | $2,527 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $95 | $225,137189 claims |
| AstraZenecaBrilinta, Farxiga | $177 | $28,64242 claims |
| Johnson & JohnsonXarelto | $65 | $15,18711 claims |
| Boehringer IngelheimJardiance | $23 | $13,54614 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 170 interventional cardiology providers in Indiana.
Other interventional cardiology in Indianapolis
- James HermillerIndianapolis$307K
- Woodrow CoreyIndianapolis$262K
- Michael BallIndianapolis$76K
- Nitesh GadeelaIndianapolis$48K
- George RevtyakIndianapolis$45K
- Scott SharpIndianapolis$41K
- Amrish MalhiIndianapolis$37K
- Jeffrey BreallIndianapolis$21K
- Sandeep DubeIndianapolis$21K
- Kevin BallIndianapolis$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.